2019-nCOV situation: 3 Feb 2020

To view images in this newsletter, please allow images and html options. 

View this email in your browser

Pandemic Threats and Health Emergencies

2019-nCOV situation: 3 Feb 2020

Welcome to this special issue of the newsletter where we highlight latest research and policy news and literature on 2019-nCVO situation

Please send your feedback, articles and reports, or questions you would like to share to Dr. Chadia Wannous via email  cwannous@yahoo.com  

Wishing you useful reading!


2019-nCOV Outbreak Situation

Situation updates:

WHO situation report no 13- 2 Feb 2020

  • No new countries have reported cases of 2019-nCoV acute respiratory disease in the last 24 hours.
  • WHO is receiving information about cases from a number of countries. As additional details become known, WHO requests countries to share information in a timely manner as specified in the guidance on Global Surveillance for human infection with novel coronavirus (2019-nCoV).
  • The first death has been reported outside of China, in the Philippines. The patient was a close contact of the first patient confirmed in the Philippines.
  • Due to the high demand for timely and trustworthy information about 2019-nCoV WHO technical risk communication and social media teams have been working closely to track and respond to myths and rumours.
    • China        Very High
    • Regional Level. High
    • Global Level.     High


China’s National Health Commission
Reported 14,380 cases of 2019-nCoV acute respiratory disease, including 2,110 severe cases, 304 deaths, and 328 patients discharged in China. Another 19,544 suspect cases have also been identified, and 137,594 individuals remain under monitoring. Additionally, the NHC reported 14 cases in Hong Kong, 7 in Macau, and 10 in Taiwan.
First death outside mainland china
DOH in the Philippines confirmed that the 44-year-old male died yesterday, February 1, 2020. Over the course of the patient’s admission, he developed severe pneumonia due to viral and bacterial infections (S. pneumoniae and Influenza B). In his last few days, the patient was stable and showed signs of improvement, however, the condition of the patient deteriorated within his last 24 hours resulting in his demise.
Fecal-oral transmission
Hubei Province has confirmed that viral nucleic acids were found in stool specimens from infected patients, suggesting that fecal-oral transmission of 2019-nCoV is possible. It was also reported that diarrhea is sometimes the first symptom, as opposed to fever or respiratory symptoms.

U.S. confirms 11th case of new coronavirus
ECDC Risk assessment in brief

  • There is high likelihood of infection for EU/EEA citizens residing in or visiting the Hubei province
  • There is moderate likelihood of infection for EU/EEA citizens in other Chinese provinces
  • There is a moderate to high likelihood of further case importation into EU/EEA countries
  • There is low likelihood of sustained human-to-human transmission within the EU/EEA.


More local spread outside China
Jan 31 Italian health ministry statement
Jan 31 Russian government statement
Jan 31 Swedish Public Health Authority statement
Jan 31 UK statement
Jan 31 BBC report
Jan 31 Japanese health ministry statement on latest local spread case
Jan 31 Japanese health ministry statement on asymptomatic evacuees
Jan 31 AFD post
Jan 31 Toronto Public Health statement
Jan 31 Singapore health ministry statement
Jan 31 KCDC statement
Consequences of the Outbreak on Economy
Stocks in Shanghai opened 8.7 percent lower, while shares in the southern Chineseboomtown of Shenzhen fell 9 percent.
Markets in China had been closed since Jan. 23 for the Lunar New Year holiday.

OPEC+ technical panel to meet Feb 4-5 to discuss coronavirus impact: sources

China counts economic cost of virus as row deepens over travel ban
The economic and diplomatic costs of China’s coronavirus epidemic mounted on Monday with investors knocking $400 billion off the value of stocks and the government accusing the United States of over-reacting to the outbreak and whipping up panic.

China accuses U.S. of scaremongering over coronavirus
Beijing on Monday accused the United States of spreading fear over a coronavirus outbreak by pulling nationals out and restricting travel instead of offering significant aid.
Control Measures

WHO declares global emergency
Updates on the respiratory illness that has infected thousands of people.
Read more about the Emergency Committee

Top WHO official says it’s not too late to stop the new coronavirus outbreak
There haven’t been many reports of health worker infections, a feature that fueled the earlier outbreaks of SARS and MERS, coronaviruses that are related to this new pathogen, provisionally called 2019-nCoV. Likewise, there has not been a lot of spread from cases discovered in other countries in tourists from China or people returning from China.

Health experts warn China travel ban will hinder coronavirus response
Wellcome pledges up to £10 million to accelerate research to support global efforts to tackle the ongoing novel coronavirus epidemic.

GSK links with CEPI to develop a vaccine for the 2019-nCoV virus
Countries measures

China builds new hospital in 10 days to combat coronavirus

Various measures taken for epidemic prevention across China
Some Hong Kong medical workers went on strike today, as part of a campaign to press the semiautonomous city to close all of its border checkpoints to visitors from mainland China.
Provinces in China have been directed to establish “psychological hotlines” to provide mental health support to the public during the 2019-nCoV epidemic. These services will be provided by a variety of governmental organizations and local partners—including health, education, and civil affairs agencies—and will provide 24-hour support. Provincial governments are directed to identify local mental health and psychologists with relevant expertise and experience to support the hotlines. Relevant guidance for providing mental health support during the epidemic is available on China’s National Health Commission website.

Plans for remdesivir trial in China
Gilead today announced that it's working with health officials in China to conduct a randomized controlled clinical trial of the experimental antiviral remdesivir for safely treating 2019-nCoV infections. In advance of that, it has expedited lab testing of the drug against 2019-nCoV samples.
Other Countries

MEPs to debate EU’s response to outbreak
Environment and Public Health MEPs will debate on Monday the Coronavirus outbreak with the Executive Director of the EU Centre for Disease Prevention and Control.
To fight coronavirus spread, the U.S. may expand ‘social distancing’ measures. But it comes at a cost

U.S. declares public health emergency over coronavirus, bans travel from China by foreign nationals

U.S. to quarantine all American citizens evacuated from Wuhan, as CDC raises pandemic possibility
Thailand sees apparent success treating virus with drug cocktail

Japan succeeds in isolating Wuhan coronavirus in step toward vaccine and test kit
Scientific publications and reports and news

Novel Coronavirus (2019-nCoV) advice for the public: Myth busters

Global Surveillance for human infection with novel coronavirus (2019-nCoV)
WHO Interim guidance

Infection prevention and control for the care of patients with 2019-nCoV in healthcare settings

Labs worldwide scramble to analyse live samples
Scientists need the pathogen to probe the biology of the emerging infection and to develop tests, drugs and vaccines.

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

Sharing research data and findings relevant to the novel coronavirus (nCoV) outbreak

Here Are 10 Misconceptions Being Spread
WHO Technical guidance


Training course:
WHO “Emerging respiratory viruses, including nCoV: methods for detection, prevention, response and control” now available
You can access the course through the following link:https://openwho.org/courses/introduction-to-ncov
By the end of this course, participants should be able to:

  • Understand the fundamental principles of emerging respiratory viruses and how to effectively respond to an outbreak.

There are two modules, as follows:

  • Module A: Introduction to Emerging respiratory viruses, including nCoV
  • Module B: Detecting Emerging respiratory viruses, including nCoV: Surveillance and Laboratory investigation

The course will take approximately 1 hour to finish.
Web: https://openwho.org



Knowledge Sharing

Thank you for reading. If you have thoughts, feedback, story ideas, or questions you would like to share or interested in partnering with us on a special event coverage, please send a note to Chadia Wannous via email cwannous@yahoo.com  


unsubscribe from this list    update subscription preferences